Market Overview

TransEnterix to Present at the 13th Annual Wells Fargo Securities Healthcare Conference


TransEnterix, Inc. (NYSE:TRXC) announced today that Todd M.
Pope, President and Chief Executive Officer, and Joseph P. Slattery,
Executive Vice President and Chief Financial Officer, will present at
the 13th Annual Wells Fargo Securities Healthcare Conference at The
Westin Copley Place in Boston, Massachusetts. The presentation is
scheduled to take place at 3:05 PM Eastern, September 6, 2018.

A live audio webcast of the conference presentation will be available
online at the investor relations page of the Company's website at
A replay of the webcast will be archived on the website for
approximately 90 days.

About TransEnterix

TransEnterix is a medical device company that is digitizing the
interface between the surgeon and the patient to improve minimally
invasive surgery by addressing the clinical and economic challenges
associated with current laparoscopic and robotic options in today's
value-based healthcare environment. The Company is focused on the
commercialization of the Senhance™ Surgical System, which digitizes
laparoscopic minimally invasive surgery. The system allows for robotic
precision, haptic feedback, surgeon camera control via eye sensing and
improved ergonomics while offering responsible economics. The Senhance
Surgical System is available for sale in the US, the EU and select other
countries. For more information, visit

View Comments and Join the Discussion!